Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin

Cancer Cell

Volumn 7, Issue 3, 2005, Pages 251-261

  Satchi Fainaro, Ronit ^a   Mamluk, Roni ^a   Wang, Ling ^c   Short, Sarah M ^a   Nagy, Janice A ^b   Feng, Dian ^b   Dvorak, Ann M ^b   Dvorak, Harold F ^b   Puder, Mark ^a   Mukhopadhyay, Debabrata ^b,c   Folkman, Judah ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIOSTATIN; CAPREOMYCIN; COPOLYMER; FUMAGILLOL CHLOROACETYLCARBAMATE; INTERLEUKIN 2; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THALIDOMIDE; TRASTUZUMAB; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; BREAST CARCINOMA; CALCIUM TRANSPORT; CANCER CHEMOTHERAPY; CARDIOVASCULAR INFLAMMATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG INHIBITION; DRUG USE; ENDOTHELIUM CELL; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; LUNG EDEMA; MALE; MEDIATOR; MELANOMA; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR BLOOD FLOW;

EID: 20244381828     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.02.007     Document Type: Article

References (50)

1. J. Abe, W. Zhou, N. Takuwa, J. Taguchi, K. Kurokawa, M. Kumada, and Y. Takuwa A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells Cancer Res. 54 1994 3407 3412
2. M. Aoyagi, A.S. Arvai, J.A. Tainer, and E.D. Getzoff Structural basis for endothelial nitric oxide synthase binding to calmodulin EMBO J. 22 2003 766 775
3. H. Aramoto, J.W. Breslin, P.J. Pappas, R.W. Hobson II, and W.N. Duran Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation Am. J. Physiol. Heart Circ. Physiol. 287 2004 H1590 H1598
4. P. Aspenstrom Effectors for the Rho GTPases Curr. Opin. Cell Biol. 11 1999 95 102
5. Y. Berthiaume, P. Boiteau, G. Fick, R. Kloiber, G.D. Sinclair, C. Fong, M.C. Poon, and R. Lafreniere Pulmonary edema during IL-2 therapy: combined effect of increased permeability and hydrostatic pressure Am. J. Respir. Crit. Care Med. 152 1995 329 335
6. J.W. Breslin, and S.Y. Yuan Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability Am. J. Physiol. Heart Circ. Physiol. 286 2004 H1057 H1062
7. T.A. Brock, H.F. Dvorak, and D.R. Senger Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells Am. J. Pathol. 138 1991 213 221
8. L.F. Brown, B.J. Dezube, K. Tognazzi, H.F. Dvorak, and G.D. Yancopoulos Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma Am. J. Pathol. 156 2000 2179 2183
9. P. Carmeliet, and D. Collen Molecular basis of angiogenesis. Role of VEGF and VE-cadherin Ann. N Y Acad. Sci. 902 2000 249 262
10. L. Claesson-Welsh Signal transduction by vascular endothelial growth factor receptors Biochem. Soc. Trans. 31 2003 20 24
11. K.P. Claffey, L.F. Brown, L.F. del Aguila, K. Tognazzi, K.T. Yeo, E.J. Manseau, and H.F. Dvorak Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis Cancer Res. 56 1996 172 181
12. R.B. Colvin, and H.F. Dvorak Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions J. Immunol. 114 1975 377 387
13. H.F. Dvorak Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J. Clin. Oncol. 20 2002 4368 4380
14. A.M. Dvorak, M.A. Lett-Brown, D.O. Thueson, K. Pyne, P.K. Raghuprasad, S.J. Galli, and J.A. Grant Histamine-releasing activity (HRA). III. HRA induces human basophil histamine release by provoking noncytotoxic granule exocytosis Clin. Immunol. Immunopathol. 32 1984 142 150
15. A.M. Dvorak, S. Kohn, E.S. Morgan, P. Fox, J.A. Nagy, and H.F. Dvorak The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation J. Leukoc. Biol. 59 1996 100 115
16. D. Feng, J.A. Nagy, J. Hipp, H.F. Dvorak, and A.M. Dvorak Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin J. Exp. Med. 183 1996 1981 1986
17. D. Feng, J.A. Nagy, A.M. Dvorak, and H.F. Dvorak Different pathways of macromolecule extravasation from hyperpermeable tumor vessels Microvasc. Res. 59 2000 24 37
18. D. Feng, J.A. Nagy, H.F. Dvorak, and A.M. Dvorak Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor-associated microvessels in man and animals Microsc. Res. Tech. 57 2002 289 326
19. N. Ferrara, and W.J. Henzel Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells Biochem. Biophys. Res. Commun. 161 1989 851 858
20. J. Folkman, and R. Kalluri Tumor angiogenesis D.W. Kufe R.E. Pollock R.R. Weichselbaum R.C.J. Bast T.S. Gansler J.F. Holland E.I. Frei Cancer Medicine 2003 B.C. Decker Inc. Hamilton, Ontario, Canada 161 194
21. J. Folkman, C.C. Haudenschild, and B.R. Zetter Long-term culture of capillary endothelial cells Proc. Natl. Acad. Sci. USA 76 1979 5217 5221
22. D. Fukumura, T. Gohongi, A. Kadambi, Y. Izumi, J. Ang, C.O. Yun, D.G. Buerk, P.L. Huang, and R.K. Jain Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability Proc. Natl. Acad. Sci. USA 98 2001 2604 2609
23. S.C. Gad, B.J. Dunn, D.W. Dobbs, C. Reilly, and R.D. Walsh Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST) Toxicol. Appl. Pharmacol. 84 1986 93 114
24. J.P. Gratton, M.I. Lin, J. Yu, E.D. Weiss, Z.L. Jiang, T.A. Fairchild, Y. Iwakiri, R. Groszmann, K.P. Claffey, Y.C. Cheng, and W.C. Sessa Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice Cancer Cell 4 2003 31 39
25. E.C. Griffith, Z. Su, B.E. Turk, S. Chen, Y.H. Chang, Z. Wu, K. Biemann, and J.O. Liu Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin Chem. Biol. 4 1997 461 471
26. A. Hall Rho GTPases and the actin cytoskeleton Science 279 1998 509 514
27. A.M. Hopkins, S.V. Walsh, P. Verkade, P. Boquet, and A. Nusrat Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function J. Cell Sci. 116 2003 725 742
28. D.E. Ingber Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology Circ. Res. 91 2002 877 887
29. D. Ingber, T. Fujita, S. Kishimoto, K. Sudo, T. Kanamaru, H. Brem, and J. Folkman Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth Nature 348 1990 555 557
30. R. Kerbel, and J. Folkman Clinical translation of angiogenesis inhibitors Nat. Rev. Cancer 2 2002 727 739
31. A.E. Koch, L.A. Harlow, G.K. Haines, E.P. Amento, E.N. Unemori, W.L. Wong, R.M. Pope, and N. Ferrara Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis J. Immunol. 152 1994 4149 4156
32. M. Kragh, M. Spang-Thomsen, and P.E. Kristjansen Time until initiation of tumor growth is an effective measure of the anti-angiogenic effect of TNP-470 on human glioblastoma in nude mice Oncol. Rep. 6 1999 759 762
33. T. Matsumoto, and L. Claesson-Welsh VEGF receptor signal transduction Sci. STKE 2001 2001 RE21
34. J.L. Mauriz, P. Linares, R.I. Macias, F. Jorquera, E. Honrado, J.L. Olcoz, P. Gonzalez, and J. Gonzalez-Gallego TNP-470 inhibits oxidative stress, nitric oxide production and nuclear factor κB activation in a rat model of hepatocellular carcinoma Free Radic. Res. 37 2003 841 848
35. S.W. McLeskey, L. Zhang, B.J. Trock, S. Kharbanda, Y. Liu, M.M. Gottardis, M.E. Lippman, and F.G. Kern Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells Br. J. Cancer 73 1996 1053 1062
36. D. Mehta, G.U. Ahmmed, B. Paria, M. Holinstat, T. Voyno-Yasenetskaya, C. Tiruppathi, R.D. Minshall, and A.B. Malik RhoA interaction with inositol 1,4,5-triphosphate receptor and transient receptor potential channel-1 regulates Ca2+ entry. Role in signaling increased endothelial permeability J. Biol. Chem. 278 2003 33492 33500 10.1074/jbc.M302401200 Published online May 22, 2003
37. A.A. Miles, and E.M. Miles Vascular reactions to histamine, histamine liberators or leukotoxins in the skin of the guinea pig J. Physiol. 118 1952 228 257
38. D.M. Milkowski, and R.A. Weiss TNP-470 T.A. Teicher Antiangiogenic Agents in Cancer Therapy 1999 Human Press Inc. Totowa, NJ 385 398
39. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J. 13 1999 9 22
40. T. Ohnishi, P.B. Sher, J.B. Posner, and W.R. Shapiro Capillary permeability factor secreted by malignant brain tumor. Role in peritumoral brain edema and possible mechanism for anti-edema effect of glucocorticoids J. Neurosurg. 72 1990 245 251
41. M.S. O'Reilly, L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, M. Moses, W.S. Lane, Y. Cao, E.H. Sage, and J. Folkman Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 1994 315 328
42. X.D. Ren, W.B. Kiosses, and M.A. Schwartz Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton EMBO J. 18 1999 578 585
43. R. Satchi-Fainaro, M. Puder, J.W. Davies, H.T. Tran, D.A. Sampson, A.K. Greene, G. Corfas, and J. Folkman Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470 Nat. Med. 10 2004 255 261
44. D.R. Senger, S.J. Galli, A.M. Dvorak, C.A. Perruzzi, V.S. Harvey, and H.F. Dvorak Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid Science 219 1983 983 985
45. S.M. Short, A. Derrien, R.P. Narsimhan, J. Lawler, D. Ingber, and B.R. Zetter Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by β1 integrins J. Cell Biol. 168 2005 643 653
46. M. Streit, P. Velasco, L. Riccardi, L. Spencer, L.F. Brown, L. Janes, B. Lange-Asschenfeldt, K. Yano, T. Hawighorst, L. Iruela-Arispe, and M. Detmar Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice EMBO J. 19 2000 3272 3282
47. Y. Takamiya, H. Brem, J. Ojeifo, T. Mineta, and R.L. Martuza AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo Neurosurgery 34 1994 869 875
48. Tjin Tham Sjin, R.M., Satchi-Fainaro, R., Birsner, A.E., Ramanujam, V.M.S., Folkman, J., and Javaherian, K. (2005). A 27 amino acid synthetic peptide corresponding to the N-terminal zinc binding domain of endostatin is responsible for its anti-tumor activity. Cancer Res., in press.
49. M. Yamaoka, T. Yamamoto, S. Ikeyama, K. Sudo, and T. Fujita Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines Cancer Res. 53 1993 5233 5236
50. H. Zeng, D. Zhao, and D. Mukhopadhyay KDR stimulates endothelial cell migration through heterotrimeric G protein Gq/11-mediated activation of a small GTPase RhoA J. Biol. Chem. 277 2002 46791 46798